Article

bizjournals.com on 2016-07-06 16:13

Seattle Genetics drug gets OK for additional cancer therapies in Europe

Related news

OK, Europe: It’s your move TechCrunch
Portugal , Germany , Greece , Estonia , Hungary
Europe needs faster action on magic mushroom, MDMA therapies, urge MEPs Politico.eu
Florence , Australia , Europe
Seattle Genetics pays $250M for drug rights seattletimes.com
Seattle Genetics gets $20 million payment bizjournals.com
Seattle Genetics names batch of new executives bizjournals.com
Analysts predict loss ahead for Seattle Genetics bizjournals.com
Phase 2 , Washington , Puget Sound
Apple, PerkinElmer rise; EQT, Seattle Genetics fall dothaneagle.com
Seattle Genetics buys biotech factory in Bothell seattletimes.com
Lake Union , Seattle , Canyon Park , Bothell
Seattle Genetics takes a new identity Seattle Times
Seattle , Bothell , Switzerland , Singapore , Canada
Europe pledges additional support for quake-hit Albania The Findlay Courier
Tirana , Kosovo , Albania , Europe
Seattle Genetics operations chief resigns to lead stealthy Seattle biotech bizjournals.com
Seattle
LAntibody-drug Conjugates Market Size 2021 Key Strategies, Applications, Trends and Opportunities | Top Brands: ImmunoGen, Takeda, Seattle Genetics, Roche…liverpoolstudentmedia.com
Africa , Middle East , Mexico , Brazil , Latin America
Collaboration can unlock the potential of gene therapies in Europe Politico.eu
France , Germany , Brussels , Europe
Biotech update: Seattle Genetics grows, medical device company disappears bizjournals.com
Seattle Genetics revenue jumps as cancer drug Adcetris takes off bizjournals.com
Seattle Genetics trials put on hold after four patient deaths seattletimes.com
Seattle Genetics will buy Cascadian Therapeutics in local biotech deal seattletimes.com
Canada